Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,3821940,half-life of elimination,"The half-life of elimination, calculated from the total excreted amount was 13 h (i.v.) and 23 h (p.o.), respectively.","Absorption, metabolism and elimination of strophanthus glycosides in man. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/3821940/),h,13,6463,DB01092,Ouabain
,3821940,half-life of elimination,"The half-life of elimination, calculated from the total excreted amount was 13 h (i.v.) and 23 h (p.o.), respectively.","Absorption, metabolism and elimination of strophanthus glycosides in man. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/3821940/),h,23,6464,DB01092,Ouabain
,3821940,half-life of elimination,After i.v.-injection 73% of the given dose was excreted by the kidneys with a half-life of elimination of 99 h.,"Absorption, metabolism and elimination of strophanthus glycosides in man. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/3821940/),h,99,6465,DB01092,Ouabain
,3821940,half-life of elimination,After oral administration 11% of the given dose were excreted with a half-life of elimination of 22 h.,"Absorption, metabolism and elimination of strophanthus glycosides in man. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/3821940/),h,22,6466,DB01092,Ouabain
,3821940,total renal excretion,Given intravenously a total renal excretion of 33% of the given dose with a half-life of elimination of 23 h was measured.,"Absorption, metabolism and elimination of strophanthus glycosides in man. ",FR-Q43,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3821940/),%,33,6467,DB01092,Ouabain
,3821940,half-life of elimination,Given intravenously a total renal excretion of 33% of the given dose with a half-life of elimination of 23 h was measured.,"Absorption, metabolism and elimination of strophanthus glycosides in man. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/3821940/),h,23,6468,DB01092,Ouabain
exceeded,7416554,bioavailability,The bioavailability of EO0122 by the oral route exceeded 80% of the oral dose.,"A preclinical study of EO-122, a new lidocaine-like antiarrhythmic drug. ",F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7416554/),%,80,28638,DB01092,Ouabain
,7416554,LD50,"The IV LD50 in mice was 22 mg/kg, and in rabbits 8.5 mg/kg.","A preclinical study of EO-122, a new lidocaine-like antiarrhythmic drug. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7416554/),[mg] / [kg],22,28639,DB01092,Ouabain
,7416554,LD50,"The IV LD50 in mice was 22 mg/kg, and in rabbits 8.5 mg/kg.","A preclinical study of EO-122, a new lidocaine-like antiarrhythmic drug. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7416554/),[mg] / [kg],8.5,28640,DB01092,Ouabain
,7416554,t1/2,"The pharmacokinetic profile of the drug fits a two-compartment open model, with t1/2 congruent to 150 min and Vd (SS) congruent to 1.5 l/kg.","A preclinical study of EO-122, a new lidocaine-like antiarrhythmic drug. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7416554/),min,150,28641,DB01092,Ouabain
,7416554,Vd,"The pharmacokinetic profile of the drug fits a two-compartment open model, with t1/2 congruent to 150 min and Vd (SS) congruent to 1.5 l/kg.","A preclinical study of EO-122, a new lidocaine-like antiarrhythmic drug. ",V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/7416554/),[l] / [kg],1.5,28642,DB01092,Ouabain
,3806778,plasma concentration,All six dogs that received procainamide converted to a normal sinus cardiac rhythm after attaining a mean plasma concentration of 33.8 micrograms/ml with a range of 48.5 micrograms/ml-25.0 micrograms/ml.,Procainamide in the dog: antiarrhythmic plasma concentrations after intravenous administration. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3806778/),[μg] / [ml],33.8,33548,DB01092,Ouabain
,2636827,absolute bioavailability,The absolute bioavailability of nasal tetraethylammonium administration was 79%.,Nasal absorption of tetraethylammonium in rats. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2636827/),%,79,43833,DB01092,Ouabain
,2882974,Basal bile flow rates,Basal bile flow rates were increased by 62% after the induction of diabetes to 88 microliter/min/kg.,Alterations in biliary excretory function by streptozotocin-induced diabetes. ,Q-Q54,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2882974/),[μl] / [kg·min],88,56721,DB01092,Ouabain
,1236603,biological half-lives,"4. The biological half-lives of tritiated ouabain, digoxin and digitoxin averaged 11 h, 2.5 days and 4.1 days, respectively, as determined by the terminal exponential elimination phase, in guinea-pigs.","Pharmacokinetics of tritiated ouabain, digoxin and digitoxin in guinea-pigs. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1236603/),h,11,61235,DB01092,Ouabain
,1236603,biological half-lives,"4. The biological half-lives of tritiated ouabain, digoxin and digitoxin averaged 11 h, 2.5 days and 4.1 days, respectively, as determined by the terminal exponential elimination phase, in guinea-pigs.","Pharmacokinetics of tritiated ouabain, digoxin and digitoxin in guinea-pigs. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1236603/),d,2.5,61236,DB01092,Ouabain
,1236603,biological half-lives,"4. The biological half-lives of tritiated ouabain, digoxin and digitoxin averaged 11 h, 2.5 days and 4.1 days, respectively, as determined by the terminal exponential elimination phase, in guinea-pigs.","Pharmacokinetics of tritiated ouabain, digoxin and digitoxin in guinea-pigs. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1236603/),d,4.1,61237,DB01092,Ouabain
,1164099,tissue/medium-ratio at equilibrium,"With digitoxin the tissue/medium-ratio at equilibrium was found to be 14 in guinea pigs and 8 in rats, with ouabain the corresponding values were 2 and 1.",[Pharmacokinetics and action of digitoxin and ouabain in the isolated hearts of guinea pigs and rats]. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1164099/),,14,69012,DB01092,Ouabain
,1164099,tissue/medium-ratio at equilibrium,"With digitoxin the tissue/medium-ratio at equilibrium was found to be 14 in guinea pigs and 8 in rats, with ouabain the corresponding values were 2 and 1.",[Pharmacokinetics and action of digitoxin and ouabain in the isolated hearts of guinea pigs and rats]. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1164099/),,8,69013,DB01092,Ouabain
,1164099,tissue/medium-ratio at equilibrium,"With digitoxin the tissue/medium-ratio at equilibrium was found to be 14 in guinea pigs and 8 in rats, with ouabain the corresponding values were 2 and 1.",[Pharmacokinetics and action of digitoxin and ouabain in the isolated hearts of guinea pigs and rats]. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1164099/),,2,69014,DB01092,Ouabain
,1164099,tissue/medium-ratio at equilibrium,"With digitoxin the tissue/medium-ratio at equilibrium was found to be 14 in guinea pigs and 8 in rats, with ouabain the corresponding values were 2 and 1.",[Pharmacokinetics and action of digitoxin and ouabain in the isolated hearts of guinea pigs and rats]. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1164099/),,1,69015,DB01092,Ouabain
,1164099,half lives,The half lives of compartment 1 (2.1-4.0 min) and those of compartment 2 (16.8-20.6 min) were similar with both glycosides and both species.,[Pharmacokinetics and action of digitoxin and ouabain in the isolated hearts of guinea pigs and rats]. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1164099/),min,2.1-4.0,69016,DB01092,Ouabain
,1164099,half lives,The half lives of compartment 1 (2.1-4.0 min) and those of compartment 2 (16.8-20.6 min) were similar with both glycosides and both species.,[Pharmacokinetics and action of digitoxin and ouabain in the isolated hearts of guinea pigs and rats]. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1164099/),min,16.8-20.6,69017,DB01092,Ouabain
,1164099,time for reaching the half maximum effect,The development and decline of the positive inotropic effect in guinea pig hearts exhibited a time course similar to that of the glycoside content in compartment 1: the time for reaching the half maximum effect was 3-4 min with ouabain and 5-6 min with digitoxin.,[Pharmacokinetics and action of digitoxin and ouabain in the isolated hearts of guinea pigs and rats]. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1164099/),min,3-4,69018,DB01092,Ouabain
,1164099,time for reaching the half maximum effect,The development and decline of the positive inotropic effect in guinea pig hearts exhibited a time course similar to that of the glycoside content in compartment 1: the time for reaching the half maximum effect was 3-4 min with ouabain and 5-6 min with digitoxin.,[Pharmacokinetics and action of digitoxin and ouabain in the isolated hearts of guinea pigs and rats]. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1164099/),min,5-6,69019,DB01092,Ouabain
,456272,half-time,"Plasma concentration fell to about a fifth of the maximal concentration within 6 min after intravenous administration, total excretion within three days being about 50%, with a half-time of 11 hours.",[Absorption and excretion of g-strophanthin after intravenous or sublingual administration (author's transl)]. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/456272/),h,11,75635,DB01092,Ouabain
,456272,Maximal plasma concentration,"Maximal plasma concentration ranged from 4.7 to 0.7 ng/ml, corresponding to levels reached 15 min or 4 hours, respectively, after intravenous administration.",[Absorption and excretion of g-strophanthin after intravenous or sublingual administration (author's transl)]. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/456272/),[ng] / [ml],4.7 to 0.7,75636,DB01092,Ouabain
,1234016,constant red cell/buffer partition ratio,A constant red cell/buffer partition ratio of 4.16+/-0.15 s.e. mean was found.,The distribution of quinidine in human blood. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1234016/),,4.16,119449,DB01092,Ouabain
,1234016,red cell/plasma partition ratio,3 Plasma reduced the uptake of quinidine so that a red cell/plasma partition ratio of 0.82+/-0.09 s.e. mean was found.,The distribution of quinidine in human blood. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1234016/),,0.82,119450,DB01092,Ouabain
,1682458,absolute bioavailabilities,"The absolute bioavailabilities for 1-, 2.5-, 3- and 8-week-old rats were 77.59, 51.52, 14.61 and 7.30%, respectively.",Effect of age on the gastrointestinal absorption of acyclovir in rats. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1682458/),%,77.59,120676,DB01092,Ouabain
,1682458,absolute bioavailabilities,"The absolute bioavailabilities for 1-, 2.5-, 3- and 8-week-old rats were 77.59, 51.52, 14.61 and 7.30%, respectively.",Effect of age on the gastrointestinal absorption of acyclovir in rats. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1682458/),%,51.52,120677,DB01092,Ouabain
,1682458,absolute bioavailabilities,"The absolute bioavailabilities for 1-, 2.5-, 3- and 8-week-old rats were 77.59, 51.52, 14.61 and 7.30%, respectively.",Effect of age on the gastrointestinal absorption of acyclovir in rats. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1682458/),%,14.61,120678,DB01092,Ouabain
,1682458,absolute bioavailabilities,"The absolute bioavailabilities for 1-, 2.5-, 3- and 8-week-old rats were 77.59, 51.52, 14.61 and 7.30%, respectively.",Effect of age on the gastrointestinal absorption of acyclovir in rats. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1682458/),%,7.30,120679,DB01092,Ouabain
,954171,volumes of distribution,"We did find, however, that young dogs had nearly twice the ouabain volumes of distribution per kilogram of body weight as adults (155.4 +/- 1.2 (SE) ml/kg vs. 80 +/- 0.6, P less than 0.0005) and that one could account for this difference with the fact that young dogs had nearly twice the plasma volume 108 +/- 9.8, vs. 68 +/- 7.3, P = 0.001) and interstitial fluid space (318 +/- 35 vs. 190 +/- 6.5, P = 0.006) as the adults.",Age-related changes in ouabain pharmacology. Ouabain exhibits a different volume of distribution in adult and young dogs. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/954171/),[ml] / [kg],155.4,172683,DB01092,Ouabain
,954171,volumes of distribution,"We did find, however, that young dogs had nearly twice the ouabain volumes of distribution per kilogram of body weight as adults (155.4 +/- 1.2 (SE) ml/kg vs. 80 +/- 0.6, P less than 0.0005) and that one could account for this difference with the fact that young dogs had nearly twice the plasma volume 108 +/- 9.8, vs. 68 +/- 7.3, P = 0.001) and interstitial fluid space (318 +/- 35 vs. 190 +/- 6.5, P = 0.006) as the adults.",Age-related changes in ouabain pharmacology. Ouabain exhibits a different volume of distribution in adult and young dogs. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/954171/),,80,172684,DB01092,Ouabain
,954171,plasma volume,"We did find, however, that young dogs had nearly twice the ouabain volumes of distribution per kilogram of body weight as adults (155.4 +/- 1.2 (SE) ml/kg vs. 80 +/- 0.6, P less than 0.0005) and that one could account for this difference with the fact that young dogs had nearly twice the plasma volume 108 +/- 9.8, vs. 68 +/- 7.3, P = 0.001) and interstitial fluid space (318 +/- 35 vs. 190 +/- 6.5, P = 0.006) as the adults.",Age-related changes in ouabain pharmacology. Ouabain exhibits a different volume of distribution in adult and young dogs. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/954171/),,108,172685,DB01092,Ouabain
,954171,plasma volume,"We did find, however, that young dogs had nearly twice the ouabain volumes of distribution per kilogram of body weight as adults (155.4 +/- 1.2 (SE) ml/kg vs. 80 +/- 0.6, P less than 0.0005) and that one could account for this difference with the fact that young dogs had nearly twice the plasma volume 108 +/- 9.8, vs. 68 +/- 7.3, P = 0.001) and interstitial fluid space (318 +/- 35 vs. 190 +/- 6.5, P = 0.006) as the adults.",Age-related changes in ouabain pharmacology. Ouabain exhibits a different volume of distribution in adult and young dogs. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/954171/),,68,172686,DB01092,Ouabain
,954171,interstitial fluid space,"We did find, however, that young dogs had nearly twice the ouabain volumes of distribution per kilogram of body weight as adults (155.4 +/- 1.2 (SE) ml/kg vs. 80 +/- 0.6, P less than 0.0005) and that one could account for this difference with the fact that young dogs had nearly twice the plasma volume 108 +/- 9.8, vs. 68 +/- 7.3, P = 0.001) and interstitial fluid space (318 +/- 35 vs. 190 +/- 6.5, P = 0.006) as the adults.",Age-related changes in ouabain pharmacology. Ouabain exhibits a different volume of distribution in adult and young dogs. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/954171/),,318,172687,DB01092,Ouabain
,954171,interstitial fluid space,"We did find, however, that young dogs had nearly twice the ouabain volumes of distribution per kilogram of body weight as adults (155.4 +/- 1.2 (SE) ml/kg vs. 80 +/- 0.6, P less than 0.0005) and that one could account for this difference with the fact that young dogs had nearly twice the plasma volume 108 +/- 9.8, vs. 68 +/- 7.3, P = 0.001) and interstitial fluid space (318 +/- 35 vs. 190 +/- 6.5, P = 0.006) as the adults.",Age-related changes in ouabain pharmacology. Ouabain exhibits a different volume of distribution in adult and young dogs. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/954171/),,190,172688,DB01092,Ouabain
,6628501,total-body clearance,Verapamil decreased total-body clearance of digoxin from 4.68 +/- 0.41 to 3.29 +/- 0.26 ml/min/kg (p less than 0.001) and increased the plasma half-life of the drug from 33.50 +/- 2.38 to 41.31 +/- 2.27 h (p less than 0.01).,Influence of verapamil on the inotropism and pharmacokinetics of digoxin. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6628501/),[ml] / [kg·min],4.68,218037,DB01092,Ouabain
,6628501,total-body clearance,Verapamil decreased total-body clearance of digoxin from 4.68 +/- 0.41 to 3.29 +/- 0.26 ml/min/kg (p less than 0.001) and increased the plasma half-life of the drug from 33.50 +/- 2.38 to 41.31 +/- 2.27 h (p less than 0.01).,Influence of verapamil on the inotropism and pharmacokinetics of digoxin. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6628501/),[ml] / [kg·min],3.29,218038,DB01092,Ouabain
,6628501,plasma half-life,Verapamil decreased total-body clearance of digoxin from 4.68 +/- 0.41 to 3.29 +/- 0.26 ml/min/kg (p less than 0.001) and increased the plasma half-life of the drug from 33.50 +/- 2.38 to 41.31 +/- 2.27 h (p less than 0.01).,Influence of verapamil on the inotropism and pharmacokinetics of digoxin. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6628501/),h,33.50,218039,DB01092,Ouabain
,6628501,plasma half-life,Verapamil decreased total-body clearance of digoxin from 4.68 +/- 0.41 to 3.29 +/- 0.26 ml/min/kg (p less than 0.001) and increased the plasma half-life of the drug from 33.50 +/- 2.38 to 41.31 +/- 2.27 h (p less than 0.01).,Influence of verapamil on the inotropism and pharmacokinetics of digoxin. ,t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6628501/),h,41.31,218040,DB01092,Ouabain
,3385724,half-life,"After iv administration to rats, procainamide was extensively metabolized to N-acetylprocainamide and displayed a half-life of 0.4 h.","Electrophysiologic and antiarrhythmic activities of 4-amino-N-[2-(diethylamino)ethyl]-3,5-dimethylbenzamide, a sterically hindered procainamide analogue. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3385724/),h,0.4,253042,DB01092,Ouabain
,3385724,half-life,"In contrast, dimethylprocainamide was not metabolized by N-acetylation, had a half-life of 1.4 h, and provided greater peak plasma concentrations.","Electrophysiologic and antiarrhythmic activities of 4-amino-N-[2-(diethylamino)ethyl]-3,5-dimethylbenzamide, a sterically hindered procainamide analogue. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3385724/),h,1.4,253043,DB01092,Ouabain
